Thu, 26 November 2015
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
Direct download: GRACEcast-406_LCAM_2015_Camidge_Kadmon_EGFR_Brain_Mets_Trial.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT